Vera Therapeutics, Inc. (VERA) Financials
VERA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 621.7 million | 122.0 million |
| Dec. 31, 2025 | 734.7 million | 130.2 million |
| Sept. 30, 2025 | 517.5 million | 118.6 million |
| June 30, 2025 | 578.5 million | 110.3 million |
VERA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -106.7 million | ? |
| Dec. 31, 2025 | -70.1 million | 11.0 million |
| Sept. 30, 2025 | -62.0 million | 9.7 million |
| June 30, 2025 | -55.0 million | 9.5 million |
VERA Net Income
No data available :(
VERA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 596.8 million | 75.0 million | - |
| Dec. 31, 2025 | 714.6 million | 74.8 million | 1.9 million |
| Sept. 30, 2025 | 497.4 million | 74.6 million | 2.1 million |
| June 30, 2025 | 556.8 million | 74.5 million | 3.1 million |
VERA Shares Outstanding
VERA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 173000 | 86.0 million | 39.1 million | - |
| Dec. 31, 2025 | 102000 | 59.6 million | 34.9 million | - |
| Sept. 30, 2025 | 133000 | 56.5 million | 27.5 million | 5.7 million |
| June 30, 2025 | 208000 | 58.1 million | 21.9 million | - |
VERA Cost of Revenue
No data available :(
VERA
Price: $34.24
52 week price:
Earnings Per Share: -5.54 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 367897
Market Capitalization: 2.2 billion